Skip to main content
. 2016 Jan 25;11(1):e0146956. doi: 10.1371/journal.pone.0146956

Table 2. NEI VFQ-25 subscale scores and ocular composite score (OCS), Mean ± S.

GH GV OP NA DA VSSF VSMH VSRD VSD D CV PV OCS*
(n = 58) (n = 58) (n = 59) (n = 59) (n = 59) (n = 59) (n = 59) (n = 59) (n = 59) (n = 54) (n = 59) (n = 59) (n = 59)
Total group (n = 59) 47.4±20.8 78.3±10.8 73.1±20.3 88.0±15.2 90.8±12.3 97.2±8.7 88.7±9.2 86.4±17.4 97.5±8.9 85.3±14.2 99.6±3.3 94.1±12.6 88.9±8.8
Sex - Male (n = 36) 46.5±23.3 76.7±10.1 71.9±21.6 88.0±14.3 91.2±12.6 97.2±9.5 88.7±9.9 86.8±17.7 97.0±10.6 88.9±12.1 99.3±4.2 95.1±11.7 88.9±9.4
- Female (n = 23) 48.9±16.3 80.9±11.5 75.0±18.5 88.0±16.8 90.2±12.0 97.3±7.5 88.6±8.1 85.9±17.4 98.2±5.6 79.8±15.7 100.0±0.0 92.4±14.0 88.9±7.9
p = 0.582 p = 0.155 p = 0.618 p = 0.648 p = 0.618 p = 0.825 p = 0.720 p = 0.822 p = 0.906 p = 0.025 p = 0.424 p = 0.386 p = 0.675
Present age (yrs) - < 45 (n = 14) 58.9±21.0 82.9±10.7 70.5±21.1 96.4±7.1 94.6±7.0 99.1±3.3 87.9±6.7 90.2±16.4 100.0±0.0 87.5±10.2 100.0±0.0 98.2±6.7 91.6±4.6
- 45–65 (n = 34) 43.9±19.8 77.6±10.9 72.1±20.7 84.6±17.1 89.7±13.6 96.0±11.0 87.9±9.8 85.7±17.2 96.6±10.9 84.4±14.7 99.3±4.3 92.6±14.5 87.6±9.7
- > 65 (n = 11) 43.2±19.7 74.5±9.3 79.5±18.8 87.9±13.1 89.4±13.0 98.9±3.8 92.0±9.7 84.1±20.2 97.0±7.7 85.2±18.5 100.0±0.0 93.2±11.7 89.3±9.4
p = 0.060 p = 0.143 p = 0.504 p = 0.026 p = 0.546 p = 0.668 p = 0.288 p = 0.523 p = 0.244 p = 0.887 p = 0.692 p = 0.363 p = 0.588
Uveitis episodes - 1 episode (n = 6) 50.0±22.4 86.7±10.3 75.0±20.9 88.9±10.1 98.6±3.4 100.0±0.0 90.6±9.5 85.4±20.0 100.0±0.0 85.0±9.1 100.0±0.0 100.0±0.0 91.9±5.1
- > 1 episode (n = 52) 47.1±21.0 77.3±10.6 72.8±20.7 87.8±15.9 89.9±12.7 96.9±9.2 88.6±9.2 87.0±17.1 97.3±9.4 85.8±14.6 99.5±3.5 94.2±11.7 88.7±9.1
p = 0.734 p = 0.048 p = 0.866 p = 0.747 p = 0.059 p = 0.343 p = 0.618 p = 0.891 p = 0.343 p = 0.594 p = 0.734 p = 0.216 p = 0.499
Laterality - Unilateral (n = 28) 50.0±19.6 79.3±11.7 80.4±18.5 89.6±14.6 92.0±9.8 97.3±7.1 90.8±7.5 88.4±16.6 98.2±6.6 88.1±11.0 100.0±0.0 95.5±9.8 90.9±7.2
- Bilateral (n = 31) 45.2±21.8 77.4±10.0 66.5±20.0 86.6±15.8 89.8±14.2 97.2±10.1 86.7±10.2 84.7±18.2 96.8±10.7 82.4±16.7 99.2±4.5 92.7±14.7 87.0±9.7
p = 0.208 p = 0.539 p = 0.009 p = 0.416 p = 0.877 p = 0.626 p = 0.096 p = 0.401 p = 0.211 p = 0.281 p = 0.342 p = 0.580 p = 0.052
Visual acuity,§ - > 0.15 (n = 7) 46.4±9.4 68.6±10.7 75.0±22.8 77.4±20.8 77.4±20.8 91.1±18.7 81.3±15.3 69.6±23.8 88.1±20.9 81.9±23.2 96.4±9.4 85.7±19.7 79.5±16.1
- ≤ 0.15 (n = 42) 47.0±21.1 78.5±10.4 71.7±20.3 89.7±12.6 92.5±9.4 98.2±5.9 89.6±7.8 88.1±15.1 98.4±5.6 86.9±13.1 100.0±0.0 94.6±11.8 89.9±6.4
p = 0.961 p = 0.023 p = 0.683 p = 0.079 p = 0.041 p = 0.146 p = 0.160 p = 0.027 p = 0.002 p = 0.880 p = 0.014 p = 0.140 p = 0.170
Systemic disease - No (n = 25) 61.5±18.0 80.8±9.3 79.5±21.6 92.0±10.1 95.0±7.2 99.5±2.5 91.5±7.8 89.5±14.3 99.7±1.7 89.1±12.7 100.0±0.0 98.0±6.9 91.9±5.5
- Yes (n = 34) 37.5±16.6 76.5±11.5 68.4±18.3 85.0±17.6 87.7±14.2 95.6±11.0 86.6±9.6 84.2±19.3 95.8±11.5 82.5±14.8 99.3±4.3 91.2±14.9 86.6±10.0
p<0.001 p = 0.121 p = 0.045 p = 0.243 p = 0.044 p = 0.101 p = 0.039 p = 0.392 p = 0.063 p = 0.079 p = 0.391 p = 0.041 p = 0.027

NEI VFQ-25: National Eye Institute Visual Functioning Questionnaire-25, GH: General Health, GV: General Vision, OP: Ocular Pain, NA: Near Activities, DA: Distance Activities, VSSF: Vision Specific Social Functioning, VSMH: Vision Specific Mental Health, VSRD: Vision Specific Role Difficulties, VSD: Vision Specific Dependency, D: Driving, CV: Color Vision, PV: Peripheral Vision, OCS: Overall Composite Score.

* Average of vision-targeted subscale scores, without GH.

Missing data in one patient.

At least one eye with LogMAR visual acuity > 0.15. Measured with Snellen chart and converted to LogMAR visual acuity, measured within six months before or after completing the NEI VFQ-25.

§ Missing data in ten patients.